4
Changes in Ownership
Milestone Pharmaceuticals Inc. Filed Acc 0001771207-26-000004
Options or other derivatives
- Chief Commercial Officer acquired 340,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Muller Lorenz Chief Commercial Officer | 2026-02-02 | Grant or award · Employee Stock Option (right to buy) | +204,000 | 204,000 | D | ||
| Muller Lorenz Chief Commercial Officer | 2026-02-02 | Grant or award · Restricted Stock Unit | +136,000 | 136,000 | D | ||
Loading xslF345X05/form4-02042026_100201.xml…